Press Release: Painmed : Centrexion Therapeutics Announces CNTX-4975 Preclinical and Clinical Data Presentations at the 35th Annual American Academy of Pain Medicine Meeting

Company will present two posters on CNTX-4975 for treatment of moderate to severe knee osteoarthritis pain;pharmacological data from preclinical and Phase 1 and 2 clinical trials describing the mechanism of action; and efficacy,safety and pharmacokinetic profile from late-stage clinical trials